Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
RecruitingOBSERVATIONAL
Enrollment
280
Participants
Timeline
Start Date
December 20, 2017
Primary Completion Date
June 7, 2037
Study Completion Date
June 25, 2037
Conditions
Human Immunodeficiency VirusCastleman's DiseaseKaposi's SarcomaViral-Associated Cancer
Trial Locations (1)
20892
RECRUITING
National Institutes of Health Clinical Center, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT03300830 - Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease | Biotech Hunter | Biotech Hunter